Onconova Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference

Onconova Therapeutics

NEWTOWN, PA — Onconova Therapeutics, Inc. (NASDAQ: ONTX) announced that the Company will be participating in the H.C. Wainwright BIOCONNECT Virtual Conference taking place January 10, 2022, through January 13, 2022.

A corporate overview presented by Steven Fruchtman, M.D., President & CEO of Onconova, will be available on-demand beginning on January 10, 2022, at 7:00 a.m. ET. The presentation can be viewed on the “Corporate Events and Presentations” section of the Onconova website and will be archived for 90 days.

Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer.

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.